EquityZen Growth Technology Fund LLC - Series 2323
Raised
$227K
Investors
—
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2323 is a private equity vehicle filed June 11, 2026, claiming exemptions under 506(b), 506(c), Rule 504, and 4(a)(5). The filing reports pre-open status with no capital raised, investor count, or minimum investment disclosed. It is part of the EquityZen platform, which operates 168 related EDGAR entities offering access to private technology company shares.
This filing reflects EquityZen's multi-series SPV model, where each numbered series typically targets a single private company's secondary shares. The use of multiple overlapping exemptions (506(b), 506(c), Rule 504, and 4(a)(5)) is unusual but consistent with EquityZen's prior filings, likely to accommodate both accredited and certain non-accredited investors across varied deal structures. Historical series from the same sponsor raised between $145K and $857K.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govIs this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
